Conexeu Sciences is trading at $2.10, down 5.41% now, as biotech shares and broader markets retreat.
- No new company-specific announcement explaining the November 5 decline appeared in the available news search. The latest listed company releases were dated October 15 and October 6.
- Reuters reported the Nasdaq fell nearly 4% as investors reassessed AI spending and data-center risks.